No Data
We're Hopeful That Anixa Biosciences (NASDAQ:ANIX) Will Use Its Cash Wisely
H.C. Wainwright Maintains Anixa Biosciences(ANIX.US) With Buy Rating, Maintains Target Price $7
H.C. Wainwright analyst Yi Chen maintains $Anixa Biosciences(ANIX.US)$ with a buy rating, and maintains the target price at $7.According to TipRanks data, the analyst has a success rate of 28.5% and
HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $7 Price Target
Anixa Biosciences Analyst Ratings
Buy Rating Affirmed for Anixa Biosciences Amid Promising Cancer Therapy Trials
Anixa Partner Gets FDA Nod for Second CAR-T Treatment to Ovarian Cancer Patient
No Data